Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol., 15 November 2021
Sec. Virology
This article is part of the Research Topic HIV-1 Genetic Diversity, Volume II View all 21 articles

Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin

\r\nJoan BacquJoan Bacqué1Elena DelgadoElena Delgado1Sonia BenitoSonia Benito1María Moreno-LorenzoMaría Moreno-Lorenzo1Vanessa MonteroVanessa Montero1Horacio GilHoracio Gil1Mnica SnchezMónica Sánchez1María Carmen Nieto-TobosoMaría Carmen Nieto-Toboso2Josefa MuozJosefa Muñoz2Miren Z. Zubero-SulibarriaMiren Z. Zubero-Sulibarria2Estíbaliz UgaldeEstíbaliz Ugalde2Elena García-BodasElena García-Bodas1Javier E. CaadaJavier E. Cañada1Jorge del RomeroJorge del Romero3Carmen RodríguezCarmen Rodríguez3Iciar Rodríguez-AvialIciar Rodríguez-Avial4Luis Elorduy-OtazuaLuis Elorduy-Otazua5Jos J. PortuJosé J. Portu6Juan García-CostaJuan García-Costa7Antonio OcampoAntonio Ocampo8Jorge J. CabreraJorge J. Cabrera8Michael M. Thomson*Michael M. Thomson1*
  • 1HIV Biology and Variability Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
  • 2Hospital Universitario de Basurto, Bilbao, Spain
  • 3Centro Sanitario Sandoval, IdISSC, Madrid, Spain
  • 4Hospital Clínico San Carlos, Madrid, Spain
  • 5Hospital Universitario de Cruces, Barakaldo, Spain
  • 6Hospital Universitario de Araba, Vitoria, Spain
  • 7Complejo Hospitalario Universitario de Ourense, Ourense, Spain
  • 8Complejo Hospitalario Universitario de Vigo, Vigo, Spain

Circulating recombinant forms (CRFs) are important components of the HIV-1 pandemic. Among 110 reported in the literature, 17 are BF1 intersubtype recombinant, most of which are of South American origin. Among these, all 5 identified in the Southern Cone and neighboring countries, except Brazil, derive from a common recombinant ancestor related to CRF12_BF, which circulates widely in Argentina, as deduced from coincident breakpoints and clustering in phylogenetic trees. In a HIV-1 molecular epidemiological study in Spain, we identified a phylogenetic cluster of 20 samples from 3 separate regions which were of F1 subsubtype, related to the Brazilian strain, in protease-reverse transcriptase (Pr-RT) and of subtype B in integrase. Remarkably, 14 individuals from this cluster (designated BF9) were Paraguayans and only 4 were native Spaniards. HIV-1 transmission was predominantly heterosexual, except for a subcluster of 6 individuals, 5 of which were men who have sex with men. Ten additional database sequences, from Argentina (n = 4), Spain (n = 3), Paraguay (n = 1), Brazil (n = 1), and Italy (n = 1), branched within the BF9 cluster. To determine whether it represents a new CRF, near full-length genome (NFLG) sequences were obtained for 6 viruses from 3 Spanish regions. Bootscan analyses showed a coincident BF1 recombinant structure, with 5 breakpoints, located in p17gag, integrase, gp120, gp41-rev overlap, and nef, which was identical to that of two BF1 recombinant viruses from Paraguay previously sequenced in NFLGs. Interestingly, none of the breakpoints coincided with those of CRF12_BF. In a maximum likelihood phylogenetic tree, all 8 NFLG sequences grouped in a strongly supported clade segregating from previously identified CRFs and from the CRF12_BF “family” clade. These results allow us to identify a new HIV-1 CRF, designated CRF66_BF. Through a Bayesian coalescent analysis, the most recent common ancestor of CRF66_BF was estimated around 1984 in South America, either in Paraguay or Argentina. Among Pr-RT sequences obtained by us from HIV-1-infected Paraguayans living in Spain, 14 (20.9%) of 67 were of CRF66_BF, suggesting that CRF66_BF may be one of the major HIV-1 genetic forms circulating in Paraguay. CRF66_BF is the first reported non-Brazilian South American HIV-1 CRF_BF unrelated to CRF12_BF.

Introduction

One of the most distinctive features of HIV-1 evolution is its high recombinogenic potential, possibly the greatest among human pathogens, which is reflected in the high frequency of unique recombinant forms (URFs), each generated in a dually- or multiply-infected individual, found wherever different genetic forms circulate in the same population (Nájera et al., 2002). Some of the HIV-1 recombinant forms have spread beyond a group of epidemiologically linked individuals, in which case they are designated circulating recombinant forms (CRFs) (Robertson et al., 2000). Currently, 110 CRFs have been reported in the literature and their number is increasing incessantly, due to both the generation of new CRFs and the identification of old previously undocumented CRFs. The proportion of CRFs in the HIV-1 pandemic has increased over time, representing around 17% infections in 2010-2015 (Hemelaar et al., 2020). Among CRFs, the most numerous are those derived from subtype B and subusbtype F1, 17 of which have been identified, most of them originated in South America, derived from the F1 variant circulating in Brazil (Louwagie et al., 1994). The first CRF_BF identified in South America was CRF12_BF, which circulates widely in Argentina and Uruguay, where URFs related to CRF12_BF are frequently found (Thomson et al., 2000, 2002; Carr et al., 2001). Subsequently, 4 CRF_BFs related to CRF12_BF, as evidenced by shared breakpoints and phylogenetic clustering, were identified in the Southern Cone of South America or neighboring countries, CRF17_BF (Aulicino et al., 2012), CRF38_BF (Ruchansky et al., 2009), CRF44_BF (Delgado et al., 2010), and CRF89_BF (Delgado et al., 2021), the last three having clear country associations, with Uruguay, Chile, and Bolivia, and Peru, respectively. Due to their common ancestry, these 5 CRFs and related URFs have been proposed to constitute a “family” of recombinant viruses (Thomson and Nájera, 2005; Zhang et al., 2010; Delgado et al., 2021). By contrast, all CRF_BFs identified in Brazil are unrelated to CRF12_BF (De Sá Filho et al., 2006; Guimarães et al., 2008; Sanabani et al., 2010; Pessôa et al., 2014; Reis et al., 2017, 2019). Here we report the identification of a new CRF_BF, found mainly in Paraguayan immigrants in Spain and also identified in Paraguay and Argentina. Interestingly, unlike all South American CRF_BFs identified to date outside of Brazil, it has no relationship with CRF12_BF.

Materials and Methods

Samples

Plasma samples from HIV-1-infected individuals were collected in 14 Spanish regions for antiretroviral drug resistance tests and for a molecular epidemiological study. The study was approved by the Committee of Research Ethics of Instituto de Salud Carlos III, Majadahonda, Madrid, Spain. The study did not require written informed consent by the study participants, as it used samples and data collected as part of routine clinical practice and patients’ data were anonymized without retaining data allowing individual identification.

RNA Extraction, Reverse Transcription-Polymerase Chain Reaction Amplification, and Sequencing

An ∼1.4 kb pol fragment in protease-reverse transcriptase (Pr-RT) was amplified from plasma RNA by Reverse Transcription-Polymerase Chain Reaction (RT-PCR) followed by nested PCR as described previously (Delgado et al., 2015) and sequenced with the Sanger method using a capillary automated sequencer. Some samples were also subject to amplification and sequencing of integrase. Near full-length genome (NFLG) sequences were obtained for selected samples by RT-PCR/nested PCR amplification from plasma RNA in four overlapping segments and sequenced by the Sanger method, as described (Delgado et al., 2002; Sierra et al., 2005; Cañada et al., 2021). Newly derived sequences are deposited in GenBank under accessions MK298150, OK011530-OK011552.

Phylogenetic Sequence Analyses

Sequences were aligned with MAFFT v7 (Katoh and Standley, 2013). Initial phylogenetic trees with all Pr-RT sequences obtained by us were constructed via approximate maximum likelihood with FastTree v2.1.10 (Price et al., 2010), using the general time reversible evolutionary model with CAT approximation to account for among-site rate heterogeneity, with assessment of node support with Shimodaira-Hasegawa (SH)-like local support values (Guindon et al., 2010). A second phylogenetic tree with the Pr-RT sequences of interest and all Pr-RT sequences from the Los Alamos HIV Sequence Database (Los Alamos National Laboratory, 2021) labeled as being from F1 subsubtype or BF1 recombinant viruses, excluding those sequences identified as BF1 recombinant within Pr-RT, according to the analyses with REGA HIV-1 Subtyping Tool v3 (Pineda-Peña et al., 2013), was also constructed with FastTree, as described above. Subsequent maximum likelihood (ML) trees with sequences of interest were constructed with W-IQ-Tree (Trifinopoulos et al., 2016), using the best-fit substitution model selected by ModelFinder program (Kalyaanamoorthy et al., 2017), with assessment of node support with the ultrafast bootstrap approximation approach (Hoang et al., 2018). Trees were visualized with MEGA v7.0 (Kumar et al., 2016) or FigTree v1.4.2 (Rambaut1).

Mosaic structures were analyzed by bootscanning (Salminen et al., 1995) with SimPlot v1.3.5 (Lole et al., 1999). In these analyses, trees were constructed using the neighbor-joining method with the Kimura 2-parameter model and a window width of 400 nucleotides. Recombinant segments identified with SimPlot were further phylogenetically analyzed via ML with W-IQ-Tree. Intersubtype breakpoint locations were also determined with jpHMM (Schultz et al., 2009).

Temporal and Geographical Estimations

The time and the location of the most recent common ancestor (MRCA) of the identified CRF was estimated using Pr-RT sequences with the Bayesian Markov chain Monte Carlo (MCMC) coalescent method implemented in BEAST v1.10.4 (Suchard et al., 2018), using a discrete trait approach. Prior to the BEAST analysis, the existence of temporal signal in the dataset was assessed with TempEst v1.5.3 (Rambaut et al., 2016), which determines the correlation of genetic divergence among sequences (measured as root-to-tip distance) with time. The BEAST analysis was performed using the SRD06 codon-based evolutionary model (with two codon position partitions: 1st+2nd, and 3rd) (Shapiro et al., 2006). A uniform prior distribution (2 x 10–4 – 2 x 10–2 subs/site/year) was used for the substitution rate. We also specified an uncorrelated lognormal relaxed clock and a Bayesian SkyGrid coalescent tree prior (Gill et al., 2013). In the SkyGrid analysis, the number of grid points was set at 50 and the time at last transition point at 60 years. The MCMCs were run for 50 million generations. We performed runs in duplicate, combining the posterior tree files with LogCombiner v1.10.4. Mixing and convergence were checked with Tracer v1.6, ensuring that effective sample size values of all parameters were >200. The posterior distribution of trees was summarized in a maximum clade credibility (MCC) tree with TreeAnnotator v1.10.4, after removal a 10% burn-in. MCC trees were visualized with FigTree. Parameter uncertainty was summarized in 95% highest posterior density (HPD) intervals.

Results

Identification of a BF Intersubtype Recombinant Cluster and Epidemiological Associations

In a molecular epidemiology study on HIV-1 in Spain we identified a cluster of 20 viruses of F1 subsubtype in Pr-RT, that in integrase, sequenced in 4 samples, were of subtype B, which was designated BF9. Inclusion in the phylogenetic analyses of Pr-RT sequences from all viruses in the Los Alamos HIV Sequence Database (Los Alamos National Laboratory, 2021) classified as being of F1 subsubtype or BF1 recombinant, excluding those sequences that were BF1 recombinant within Pr-RT, according to REGA HIV-1 Subtyping Tool, identified 10 additional viruses belonging to BF9, from Argentina (n = 4), Spain (n = 3), Paraguay (n = 1), Brazil (n = 1), and Italy (n = 1) (Figure 1 and Supplementary Figure 1). Pr-RT sequences of the BF9 cluster were most closely related to F1 viruses of the Brazilian variant (Figure 1). Epidemiological data of the 20 samples of the BF9 cluster from Spain processed by us are shown in Table 1. Remarkably, 14 individuals were from Paraguay [with the remaining 6 being from Spain (n = 4), Argentina, and Equatorial Guinea] and all 3 other database sequences from samples collected in Spain were from Latin Americans, one each from Paraguay, Argentina, and an unspecified country. Transmission was predominantly heterosexual, but 7 were men who have sex with men (MSM), the sequences of 5 of whom branched in a subcluster (Figure 1).

FIGURE 1
www.frontiersin.org

Figure 1. Maximum likelihood tree of Pr-RT sequences of BF9 cluster constructed with IQ-Tree. Sequences used in this analysis were those from the BF9 cluster shown in the tree of Supplementary Figure 1, constructed with FastTree, plus sequences of F1 subsubtype from different countries and of CRF_BFs that are of nonrecombinant F1 subsubtype in Pr-RT, plus two F2 sequences used as outgroups. Names of sequences obtained by us, all collected in Spain, are in bold type. In database sequences, the country of sample collection is indicated before the virus name with the 2-letter ISO country code. After the names of viruses of the BF9 cluster, the 2-letter ISO code of country of origin of the patient and/or the transmission route, when known, are shown in parentheses. Only ultrafast bootstrap values ≥80% are shown. PY: Paraguay; AR: Argentina; ES: Spain; BR: Brazil; IT: Italy; GQ: Equatorial Guinea; Lat Am: Latin America (unknown country); MSM: man who has sex with men; HT: heterosexual; SX-M: male with unspecified sexual acquisition of HIV-1.

TABLE 1
www.frontiersin.org

Table 1. Epidemiological data of patients and GenBank accessions of sequences.

Analyses of Near Full-Length Genome Sequences and Identification of a New Circulating Recombinant Form

To determine whether viruses from the BF9 cluster represent a new CRF, we obtained NFLG sequences from 6 samples from 3 Spanish regions and analyzed their mosaic structures by bootscanning. Two additional NFLG sequences of BF recombinant viruses from databases were also analyzed by bootscanning, both from Paraguay: 02PY_PSP0094, that branched in the BF9 cluster in Pr-RT, and 02PY_PSP0093, that showed high similarity to NFLGs of the BF9 cluster in BLAST searches of the Los Alamos database. All 8 analyzed genomes showed coincident mosaic structures, with 5 breakpoints, located in p17gag, integrase, gp120, gp41-rev overlap, and nef (Figure 2). Breakpoints were more precisely located using the midpoint of B-F1 transitions, according to the positions where 75% consensuses of subtype B and the F1 Brazilian strain genomes differ, in HXB2 positions 950, 4327, 6486, 8498, and 9161. Breakpoint locations were also determined with jpHMM (Supplementary Table), which also found 5 breakpoints for each virus in intervals overlapping those of the other analyzed viruses and the 75% consensus B-F1 transition intervals in all cases except the breakpoint interval in nef of MD497796, that did not overlap the consensus B-F1 transition interval, and that in p17gag of PV106451, that was not detected by jpHMM. ML phylogenetic trees constructed with each interbreakpoint fragment confirmed the subtype assignation determined with bootscanning (Figure 3).

FIGURE 2
www.frontiersin.org

Figure 2. Bootscan analyses of 6 NFLG sequences of viruses of the BF9 cluster obtained by us and of two BF1 database NFLG sequences from Paraguay, 02PY_PSP0093 and 02PY_PSP0094. The horizontal axis represents the position in the HXB2 genome of the midpoint of a 400 nt window moving in 20 nt increments and the vertical axis represents bootstrap values supporting clustering with subtype reference sequences.

FIGURE 3
www.frontiersin.org

Figure 3. Phylogenetic trees of interbreakpoint genome segments of the BF recombinant viruses analyzed by bootscanning, constructed with IQ-Tree. HXB2 positions delimiting the analyzed segments are indicated on top of the trees. Sequence names of BF viruses are in bold type. Names of subtype references are preceded by the corresponding subtype name. Only ultrafast bootstrap values ≥80% are shown.

In an ML tree constructed with the 7 NFLG genomes of the BF9 cluster and 02PY_PSP0093, all 8 genomes grouped in a strongly supported clade segregating away from all other CRF_BFs and of the clade formed by the 5 CRF_BFs of the CRF12_BF family (Figure 4). It should be pointed out that 02PY_PSP0093 did not branch in the BF9 cluster in the tree of Pr-RT (Supplementary Figure 1), which suggests that the Pr-RT segment of this virus could derive from secondary recombination with an F1 strain different from the parental F1 strain of all other BF9 viruses.

FIGURE 4
www.frontiersin.org

Figure 4. Maximum likelihood tree of NFLG sequences of viruses of the BF9 cluster and PY02_PSP0094, constructed with IQ-Tree. References of all published CRF_BFs and of HIV-1 subtypes are also included in the analysis. The tree is rooted with SIVcpz virus MB66. Names of sequences obtained by us are in bold type. In reference sequences, the subtype or CRF is indicated before the virus name. Only ultrafast bootstrap values ≥90% are shown.

These results, therefore, allow to define a new CRF, which was designated CRF66_BF, whose mosaic structure is shown in Figure 5.

FIGURE 5
www.frontiersin.org

Figure 5. Mosaic structure of CRF66_BF. Breakpoint positions are numbered as in the HXB2 genome. The drawing was made using the Recombinant HIV-1 Drawing Tool https://www.hiv.lanl.gov/content/sequence/DRAW_CRF/recom_mapper.html.

Prevalence of CRF66_BF Among HIV-1-Infected Paraguayans Residing in Spain and Among Sequences From Samples Collected in Paraguay Deposited at the HIV-1 Sequence Database

Among 67 HIV-1-infected Paraguayans residing in Spain studied by us, CRF66_BF was the most common non-subtype B genetic form, representing 20.9% (14 of 67) of total infections, 48.3% (14 of 29) of non-subtype B infections, and 60.1% (14 of 23) of F1/BF1 infections.

At the Los Alamos HIV Sequence Database, there are HIV-1 sequences from samples collected in Paraguay from only 23 individuals, of which 12 are NFLG sequences from samples collected in 2002 or 2003 and 11 are env V3 region sequences from samples with unknown collection years. In phylogenetic analyses, 2 of 12 NFLG and 1 of 11 V3 sequences [combined, 3 (13%) of 23 viruses] branched in the clade formed by CRF66_BF viruses (Supplementary Figure 2). However, due to the short length of the Paraguayan V3 sequences, the reliability of the tree of this segment for identifying CRF66_BF viruses is uncertain, since several CRF_BF and the subtype G references branched apart from other references of the same genetic form, and one CRF72_BF reference branched within the CRF66_BF clade.

Temporal and Geographical Estimations of CRF66_BF Origin

To estimate the time and place of origin of CRF66_BF, Pr-RT sequences where analyzed with a Bayesian coalescent method with BEAST 1.10.4. Prior to this analysis, TempEst analysis determined that there was an adequate temporal signal in the dataset (r2 = 0.5871). In the BEAST analysis, for the sequences corresponding to South American individuals residing in Spain, the assigned location trait was their country of origin, rather than their place of residence. This was done because most individuals harboring CRF66_BF identified in Spain were of South American origin (mostly from Paraguay) and because we found no definitive evidence of the local circulation of CRF66_BF in Spain, as reflected in clusters mainly comprising Spanish individuals. Therefore, we assumed that South Americans harboring CRF66_BF viruses had acquired HIV-1 in their countries of origin. In this analysis, the substitution rate was estimated at 1.987 x 10–3 subs/site/year (95% HPD, 8.885 x 10–4 – 3.282 x 10–3 subs/site/year) and the time of the MRCA of CRF66_BF was estimated around 1984 (95% HPD, 1970–1996), with its most probable location in Paraguay (PP = 0.76), with Argentina in second place (PP = 0.22) (Figure 6). Considering the possibility that local subclusters each found in one city could represent local transmissions, we performed a second analysis in which we assigned the country of location of the most recent diagnoses of such clusters to Spain, irrespective of the countries of origin of the individuals. In this analysis, Paraguay was also estimated as the most probable location of the MRCA of CRF66_BF, although with a lower support (PP = 0.55), and the support for Argentina increased to a PP = 0.42 (Supplementary Figure 3).

FIGURE 6
www.frontiersin.org

Figure 6. Maximum clade credibility tree of CRF66_BF Pr-RT sequences. Branch colors indicate, for terminal branches, country of sample collection or, for South American individuals residing in Spain, of origin of the individual, which was used as location trait (see Methods), and for internal branches, the most probable location country of the subtending node, according to the legend on the upper left. For database sequence 524026, from a sample collected in Spain, location was assigned to Paraguay as the most probably country of origin, although the only available information in the GenBank entry is that the individual was from Latin America, because 15 (88.2%) of 17 Latin Americans with CRF66_BF sampled in Spain were from Paraguay. Nodes supported by PP ≥ 0.95 and PP 0.9–0.949 are indicated with filled and unfilled circles, respectively. The two most probable countries at the root of the tree are indicated, together with the PPs supporting each location and the time of the MRCA (mean value, with 95% HPD interval in brackets).

Discussion

The results of this study allow to define a new HIV-1 CRF, designated CRF66_BF, which is the 18th reported CRF derived from subtypes B and F. Samples harboring CRF66_BF were collected in 5 countries, in South America (Argentina, Paraguay, and Brazil) and Western Europe (Spain and Italy), with a majority collected in Spain. However, of samples collected in Spain, a great majority were from Paraguayan individuals. Bayesian coalescent analyses (performed with the assumption that South American individuals living in Spain harboring CRF66_BF viruses had acquired them in their countries of origin), pointed to a most probable origin of CRF66_BF in Paraguay (PP = 0.76), with Argentina being the second most probable location (PP = 0.22). When the analysis was performed assigning the most recently diagnosed samples of clusters found in a single Spanish city to Spain as the location trait, irrespective of the country of origin of the individual, the PPs for a MRCA in Paraguay or Argentina were not very different (0.55 vs. 0.42, respectively). Therefore, the results point to a South American origin of CRF66_BF, either in Paraguay or Argentina, without a definitive support for either country. However, given the great predominance of Paraguayans among CRF66_BF-infected individuals living in Spain, we cannot rule out that the same could happen in Argentina, where Paraguayans represent the largest immigrant national group (Instituto Nacional de Estadísticas y Censos, República Argentina, 2021). If this was the case, and information on country of origin of the sampled individuals living in Argentina was included in the analyses, it is possible that the support for a root of the CRF66_BF tree in Paraguay would increase.

The estimated date of origin of CRF66_BF around 1984 is consistent with the published estimated origin of the Brazilian F1 strain (around 1977) (Bello et al., 2007) and is similar to those of other South American CRF_BFs (CRF12, CRF28/29, CRF38, CRF89, and CRF90) reported in the literature (Bello et al., 2010; Ristic et al., 2011; Reis et al., 2017; Delgado et al., 2021), although younger than some other estimates for CRF12_BF in the 1970s (Dilernia et al., 2011; Delgado et al., 2021) and older than the estimate for CRF99_BF, around 1993 (Reis et al., 2017).

Among HIV-1-infected Paraguayans residing in Spain studied by us, there was relatively high prevalence (21%) of CRF66_BF infections, which suggests that CRF66_BF could be one of the major HIV-1 genetic forms circulating in Paraguay. A better knowledge of the current prevalence of CRF66_BF in Paraguay would require sequencing a representative sample of recent HIV-1 diagnoses in the country. However, HIV-1 sequences from only 23 patients sampled in Paraguay are available at the Los Alamos HIV Sequence database, and the most recent molecular epidemiological study published to date involves the analysis of sequences from 55 samples collected 18 to 19 years ago (Aguayo et al., 2008), which are not available in public databases.

Notably, CRF66_BF, unlike all other non-Brazilian CRF_BFs identified to date in South America (CRF12_BF, CRF17_BF, CRF38_BF, CRF44_BF, and CRF89_BF, all circulating in the Southern Cone or neighboring countries), is unrelated to CRF12_BF, as deduced from the lack of breakpoint coincidence and of phylogenetic clustering with CRF12_BF. This implies that CRF66_BF originated independently from viruses of the CRF12_BF family, with a presumable ancestry in Brazil, where B and F1 viruses are circulating (Louwagie et al., 1994).

CRF66_BF is the 5th CRF of South American ancestry originally identified in Western Europe [after CRF42_BF (Struck et al., 2015), CRF47_BF (Fernández-García et al., 2010), CRF60_BC (Simonetti et al., 2014), and CRF89_BF (Delgado et al., 2021)], which, together with the reported propagation of HIV-1 variants of South America origin among the European population (de Oliveira et al., 2010; Collaço Verás et al., 2012; Thomson et al., 2012; Lai et al., 2014; Carvalho et al., 2015; Delgado et al., 2015; Fabeni et al., 2015, 2020; Vinken et al., 2019), points to an increasing relationship between the HIV-1 epidemics in both continents. This reflects migratory fluxes, most notably in Spain, where around 2.5 million South Americans live, representing nearly 40% of the migrant population (Instituto Nacional de Estadística, 2021a), and immigration from South America has increased greatly in recent years (Instituto Nacional de Estadística, 2021b) (Supplementary Figure 4). Considering the large and increasing South American immigrant population in Europe and the relative scarcity of HIV-1 sequences available in public databases from some South American countries (such as Colombia, Guyana, Ecuador, Bolivia, Paraguay, Chile, and Uruguay) (Supplementary Figure 5), studies on HIV-1 genetic diversity and molecular epidemiology among South American immigrants living in Europe could provide novel insights into the HIV-1 epidemics in their countries of origin, although the acquisition of some HIV-1 infections in their European countries of residence, reflected in branching in European clusters, should be taken into account (Osorno et al., 11th Conference on HIV Science, abstract PEC252, 18-21 July 20212), as well as on the diffusion of South American HIV-1 variants in Europe.

It is interesting to note that although transmission of CRF66_BF is predominantly via heterosexual contact, most individuals in a cluster are MSM (Figure 1), which suggests diffusion from a heterosexual to a MSM network. HIV-1 propagation between heterosexual and MSM networks has also been reported for CRF89_BF (Delgado et al., 2021) and for a large CRF02_AG cluster in Spain (Delgado et al., 2019), although in the latter case the direction of propagation was from MSM to heterosexuals.

One of the essential tasks of Biology is naming and classifying organisms. In this work, we have accomplished this task by identifying a new HIV-1 circulating recombinant form, derived from subtypes B and F1, named CRF66_BF. CRF66_BF most likely originated in South America, either in Paraguay or Argentina, and, unlike all non-Brazilian South American CRFs identified to date, is unrelated to CRF12_BF. The identification and genetic characterization of HIV-1 variants is the first and necessary step for molecular epidemiological studies examining their geographic dissemination, growth dynamics, and epidemiological associations, as well as for analyzing their biological properties, such as pathogenic and transmissibility potentials, response to antiretroviral therapies, and susceptibility to immune responses inducible by vaccines. Such studies on CRF66_BF and other South American CRFs may be the subject of future work.

Data Availability Statement

The names of the repository and accession numbers can be found in the article (Materials and Methods and Table 1).

Ethics Statement

The studies involving human participants were reviewed and approved by Committe of Research Ethics, Instituto de Salud Carlos III, Madrid, Spain. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.

Author Contributions

MT and ED conceived the study and supervised the experimental work. JB, MT, and ED processed sequences and performed phylogenetic analyses. MT performed phylodynamic analyses. HG performed data curation. JB, SB, MM-L, VM, MS, EG-B, and JEC performed experimental work. MN-T, JM, MZ-S, EU, JR, CR, IR-A, LE-O, JP, JG-C, AO, and JJC obtained samples and epidemiological data from patients. MT, ED, and HG wrote the manuscript. All authors read and approved the manuscript.

Funding

This work was funded through Acción Estratégica en Salud Intramural (AESI), Instituto de Salud Carlos III, projects PI16CIII/00033 and PI19CIII/00042; Red de Investigación en SIDA (RIS), Instituto de Salud Carlos III, Subdirección General de Evaluación y Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I+D+I, project RD16ISCIII/0002/0004; and scientific agreements with Consellería de Sanidade, Government of Galicia (MVI 1004/16) and Osakidetza-Servicio Vasco de Salud, Government of Basque Country (MVI 1001/16).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We thank José Antonio Taboada, from Consellería de Sanidade, Xunta de Galicia, and Daniel Zulaika, from Osakidetza-Servicio Vasco de Salud, for their support of this study, and the personnel at the Genomic Unit, Instituto de Salud Carlos III, for technical assistance in sequencing.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2021.774386/full#supplementary-material

Footnotes

  1. ^ http://tree.bio.ed.ac.uk/software/figtree/
  2. ^ https://ias2021.org/wp-content/uploads/2021/07/IAS2021_Abstracts_web.pdf

References

Aguayo, N., Laguna-Torres, V. A., Villafane, M., Barboza, A., Sosa, L., Chauca, G., et al. (2008). Epidemiological and molecular characteristics of HIV-1 infection among female commercial sex workers, men who have sex with men and people living with AIDS in Paraguay. Rev. Soc. Bras. Med. Trop. 41, 225–231. doi: 10.1590/s0037-86822008000300001

PubMed Abstract | CrossRef Full Text | Google Scholar

Aulicino, P. C., Gómez-Carrillo, M., Bello, G., Rocco, C., Mangano, A., Carr, J., et al. (2012). Characterization of full-length HIV-1 CRF17_BF genomes and comparison to the prototype CRF12_BF strains. Infect. Genet. Evol. 12, 443–447.

Google Scholar

Bello, G., Aulicino, P. C., Ruchansky, D., Guimarães, M. L., López-Galíndez, C., Casado, C., et al. (2010). Phylodynamics of HIV-1 circulating recombinant forms 12_BF and 38_BF in Argentina and Uruguay. Retrovirology 7:22. doi: 10.1186/1742-4690-7-22

PubMed Abstract | CrossRef Full Text | Google Scholar

Bello, G., Eyer-Silva, W. A., Couto-Fernandez, J. C., Guimarães, M. L., Chequer-Fernandez, S. L., Teixeira, S. L., et al. (2007). Demographic history of HIV-1 subtypes B and F in Brazil. Infect. Genet. Evol. 7, 263–270.

Google Scholar

Cañada, J. E., Delgado, E., Gil, H., Sánchez, M., Benito, S., García-Bodas, E., et al. (2021). Identification of a new HIV-1 BC intersubtype circulating recombinant form (CRF108_BC) in Spain. Viruses 13:93. doi: 10.3390/v13010093

PubMed Abstract | CrossRef Full Text | Google Scholar

Carr, J. K., Avila, M., Gomez Carrillo, M., Salomon, H., Hierholzer, J., Watanaveeradej, V., et al. (2001). Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 15, F41–F47. doi: 10.1097/00002030-200110190-00002

PubMed Abstract | CrossRef Full Text | Google Scholar

Carvalho, A., Costa, P., Triunfante, V., Branca, F., Rodrigues, F., Santos, C. L., et al. (2015). Analysis of a local HIV-1 epidemic in Portugal highlights established transmission of non-B and non-G subtypes. J. Clin. Microbiol. 53, 1506–1514. doi: 10.1128/JCM.03611-14

PubMed Abstract | CrossRef Full Text | Google Scholar

Collaço Verás, N. M., Gray, R. R., de Macedo Brígido, L. F., Rodrigues, R., and Salemi, M. (2012). High-resolution phylogenetics and phylogeography of human immunodeficiency virus type 1 subtype C epidemic in South America. J. Gen. Virol. 92, 1698–1709. doi: 10.1099/vir.0.028951-0

PubMed Abstract | CrossRef Full Text | Google Scholar

de Oliveira, T., Pillay, D., and Gifford, R. J. (2010). The HIV-1 subtype C epidemic in South America is linked to the United Kingdom. PLoS One 5:e9311. doi: 10.1371/journal.pone.0009311

PubMed Abstract | CrossRef Full Text | Google Scholar

De Sá Filho, D. J., Sucupira, M. C., Caseiro, M. M., Sabino, E. C., Diaz, R. S., and Janini, L. M. (2006). Identification of two HIV type 1 circulating recombinant forms in Brazil. AIDS Res. Hum. Retroviruses 22, 1–13. doi: 10.1089/aid.2006.22.1

PubMed Abstract | CrossRef Full Text | Google Scholar

Delgado, E., Benito, S., Montero, V., Cuevas, M. T., Fernández-García, A., Sánchez-Martínez, M., et al. (2019). Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain. Front. Microbiol. 10:655. doi: 10.3389/fmicb.2019.00655

PubMed Abstract | CrossRef Full Text | Google Scholar

Delgado, E., Cuevas, M. T., Domínguez, F., Vega, Y., Cabello, M., Fernández-García, A., et al. (2015). Phylogeny and phylogeography of a recent HIV-1 subtype F outbreak among men who have sex with men in Spain deriving from a cluster with a wide geographic circulation in Western Europe. PLoS One 10:e0143325. doi: 10.1371/journal.pone.0143325

PubMed Abstract | CrossRef Full Text | Google Scholar

Delgado, E., Fernández-García, A., Pérez-Losada, M., Moreno-Lorenzo, M., Fernández-Miranda, I., Benito, S., et al. (2021). Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America. Sci. Rep. 11:11442. doi: 10.1038/s41598-021-90023-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Delgado, E., Ríos, M., Fernández, J., Pérez-Alvarez, L., Nájera, R., and Thomson, M. M. (2010). Identification of a new HIV type 1 BF intersubtype circulating recombinant form (CRF44_BF) in Chile. AIDS Res. Hum. Retroviruses 26, 821–826. doi: 10.1089/aid.2010.0006

PubMed Abstract | CrossRef Full Text | Google Scholar

Delgado, E., Thomson, M. M., Villahermosa, M. L., Sierra, M., Ocampo, A., Miralles, C., et al. (2002). Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. J. Acquir. Immune Defic. Syndr. 29, 536–543. doi: 10.1097/00126334-200204150-00016

PubMed Abstract | CrossRef Full Text | Google Scholar

Dilernia, D. A., Jones, L. R., Pando, M. A., Rabinovich, R. D., Damilano, G. D., Turk, G., et al. (2011). Analysis of HIV type 1 BF recombinant sequences from South America dates the origin of CRF12_BF to a recombination event in the 1970s. AIDS Res. Hum. Retroviruses 27, 569–578. doi: 10.1089/AID.2010.0118

PubMed Abstract | CrossRef Full Text | Google Scholar

Fabeni, L., Alteri, C., Orchi, N., Gori, C., Bertoli, A., Forbici, F., et al. (2015). Recent transmission clustering of HIV-1 C and CRF17_BF strains characterized by NNRTI-related mutations among newly diagnosed men in Central Italy. PLoS One 10:e0135325. doi: 10.1371/journal.pone.0135325

PubMed Abstract | CrossRef Full Text | Google Scholar

Fabeni, L., Santoro, M. M., Lorenzini, P., Rusconi, S., Gianotti, N., Costantini, A., et al. (2020). Evaluation of HIV transmission clusters among natives and foreigners living in Italy. Viruses 12:791. doi: 10.3390/v12080791

PubMed Abstract | CrossRef Full Text | Google Scholar

Fernández-García, A., Pérez-Alvarez, L., Cuevas, M. T., Delgado, E., Muñoz-Nieto, M., Cilla, G., et al. (2010). Identification of a new HIV type 1 circulating BF intersubtype recombinant form (CRF47_BF) in Spain. AIDS Res. Hum. Retroviruses 26, 827–832. doi: 10.1089/aid.2009.0311

PubMed Abstract | CrossRef Full Text | Google Scholar

Gill, M., Lemey, P., Faria, N., Rambaut, A., Shapiro, B., and Suchard, M. (2013). Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci. Mol. Biol. Evol. 30, 713–724. doi: 10.1093/molbev/mss265

PubMed Abstract | CrossRef Full Text | Google Scholar

Guimarães, M. L., Eyer-Silva, W. A., Couto-Fernandez, J. C., and Morgado, M. G. (2008). Identification of two new CRF_BF in Rio de Janeiro State, Brazil. AIDS 22, 433–435. doi: 10.1097/QAD.0b013e3282f47ad0

PubMed Abstract | CrossRef Full Text | Google Scholar

Guindon, S., Dufayard, J. F., Lefort, V., Anisimova, M., Hordijk, W., and Gascuel, O. (2010). New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 59, 307–321. doi: 10.1093/sysbio/syq010

PubMed Abstract | CrossRef Full Text | Google Scholar

Hemelaar, J., Elangovan, R., Yun, J., Dickson-Tetteh, L., Kirtley, S., Gouws-Williams, E., et al. (2020). Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global survey. Lancet HIV 7, e772–e781. doi: 10.1016/S1473-3099(18)30647-9

CrossRef Full Text | Google Scholar

Hoang, D. T., Chernomor, O., von Haeseler, A., Minh, B. Q., and Vinh, L. S. (2018). UFBoot2: improving the ultrafast bootstrap approximation. Mol. Biol. Evol. 35, 518–522. doi: 10.1093/molbev/msx281

PubMed Abstract | CrossRef Full Text | Google Scholar

Instituto Nacional de Estadística (2021a). Principales Series De Población Desde 1998. Available online at: https://www.ine.es/jaxi/Datos.htm?path=/t20/e245/p08/l0/, andfile=01006.px#!tabs-tabla (Accessed August 17, 2021).

Google Scholar

Instituto Nacional de Estadística (2021b). Migraciones Exteriores. Available online at: https://www.ine.es/jaxiT3/Tabla.htm?t=24295 (Accessed August 17, 2021).

Google Scholar

Instituto Nacional de Estadísticas y Censos, República Argentina (2021). Censo 2010. Available online at: https://www.indec.gob.ar/indec/web/Nivel4-Tema-2-41-135 (Accessed August 17, 2021).

Google Scholar

Kalyaanamoorthy, S., Minh, B. Q., Wong, T. K. F., von Haeseler, A., and Jermiin, L. S. (2017). ModelFinder: fast model selection for accurate phylogenetic estimates. Nat. Methods 14, 587–589. doi: 10.1038/nmeth

CrossRef Full Text | Google Scholar

Katoh, K., and Standley, D. M. (2013). MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772–780. doi: 10.1093/molbev/mst010

PubMed Abstract | CrossRef Full Text | Google Scholar

Kumar, S., Stecher, G., and Tamura, K. (2016). MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 33, 1870–1874. doi: 10.1093/molbev/msw054

PubMed Abstract | CrossRef Full Text | Google Scholar

Lai, A., Bozzi, G., Franzetti, M., Binda, F., Simonetti, F. R., Micheli, V., et al. (2014). Phylogenetic analysis provides evidence of interactions between Italian heterosexual and South American homosexual males as the main source of national HIV-1 subtype C epidemics. J. Med. Virol. 86, 729–736. doi: 10.1002/jmv.23891

PubMed Abstract | CrossRef Full Text | Google Scholar

Lole, K. S., Bollinger, R. C., Paranjape, R. S., Gadkari, D., Kulkarni, S. S., Novak, N. G., et al. (1999). Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73, 152–160. doi: 10.1128/JVI.73.1.152-160.1999

PubMed Abstract | CrossRef Full Text | Google Scholar

Los Alamos National Laboratory (2021). HIV Sequence Database. Available online at: https://www.hiv.lanl.gov/content/sequence/HIV/mainpage.html (Accessed August 17, 2021).

Google Scholar

Louwagie, J., Delwart, E. L., Mullins, J. I., McCutchan, F. E., Eddy, G., and Burke, D. S. (1994). Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res. Hum. Retroviruses 10, 561–567. doi: 10.1089/aid.1994.10.561

PubMed Abstract | CrossRef Full Text | Google Scholar

Nájera, R., Delgado, E., Pérez-Álvarez, L., and Thomson, M. M. (2002). Genetic recombination and its role in the development of the HIV-1 pandemic. AIDS 16, S3–S16. doi: 10.1097/00002030-200216004-00002

PubMed Abstract | CrossRef Full Text | Google Scholar

Pessôa, R., Watanabe, J. T., Calabria, P., Felix, A. C., Loureiro, P., Sabino, E. C., et al. (2014). Deep sequencing of HIV-1 near full-length proviral genomes identifies high rates of BF1 recombinants including two novel circulating recombinant forms (CRF) 70_BF1 and a disseminating 71_BF1 among blood donors in Pernambuco, Brazil. PLoS One 9:e112674. doi: 10.1371/journal.pone.0112674

PubMed Abstract | CrossRef Full Text | Google Scholar

Pineda-Peña, A. C., Faria, N. R., Imbrechts, S., Libin, P., Abecasis, A. B., Deforche, K., et al. (2013). Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools. Infect. Genet. Evol. 19, 337–348. doi: 10.1016/j.meegid.2013.04.032

PubMed Abstract | CrossRef Full Text | Google Scholar

Price, M. N., Dehal, P. S., and Arkin, A. P. (2010). FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS One 5:e9490. doi: 10.1371/journal.pone.0009490

PubMed Abstract | CrossRef Full Text | Google Scholar

Rambaut, A., Lam, T. T., Max, C. L., and Pybus, O. G. (2016). Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). Virus Evol. 2:vew007. doi: 10.1093/ve/vew007

PubMed Abstract | CrossRef Full Text | Google Scholar

Reis, M. N. G., Bello, G., Guimarães, M. L., and Stefani, M. M. A. (2017). Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions. PLoS One 12:e0178578. doi: 10.1371/journal.pone.0178578

PubMed Abstract | CrossRef Full Text | Google Scholar

Reis, M. N. G., Guimarães, M. L., Bello, G., and Stefani, M. M. A. (2019). Identification of new HIV-1 circulating recombinant forms CRF81_cpx and CRF99_BF1 in Central Western Brazil and of Unique BF1 recombinant forms. Front. Microbiol. 10:97. doi: 10.3389/fmicb.2019.00097

PubMed Abstract | CrossRef Full Text | Google Scholar

Ristic, N., Zukurov, J., Alkmim, W., Diaz, R. S., Janini, L. M., and Chin, M. P. (2011). Analysis of the origin and evolutionary history of HIV-1 CRF28_BF and CRF29_BF reveals a decreasing prevalence in the AIDS epidemic of Brazil. PLoS One 6:e17485. doi: 10.1371/journal.pone.0017485

PubMed Abstract | CrossRef Full Text | Google Scholar

Robertson, D. L., Anderson, J. P., Bradac, J. A., Carr, J. K., Foley, B., Funkhouser, R. K., et al. (2000). HIV-1 nomenclature proposal. Science 288, 55–56. doi: 10.1126/science.288.5463.55d

PubMed Abstract | CrossRef Full Text | Google Scholar

Ruchansky, D., Casado, C., Russi, J. C., Arbiza, J. R., and López-Galíndez, C. (2009). Identification of a new HIV type 1 circulating recombinant form (CRF38_BF1) in Uruguay. AIDS Res. Hum. Retroviruses 25, 351–356. doi: 10.1089/aid.2008.0248

PubMed Abstract | CrossRef Full Text | Google Scholar

Salminen, M. O., Carr, J. K., Burke, D. S., and McCutchan, F. E. (1995). Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res. Hum. Retroviruses 11, 1423–1425. doi: 10.1089/aid.1995.11.1423

PubMed Abstract | CrossRef Full Text | Google Scholar

Sanabani, S. S., Pastena, E. R., Neto, W. K., Martinez, V. P., and Sabino, E. C. (2010). Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in São Paulo Brazil. Virol. J. 7:74. doi: 10.1186/1743-422X-7-74

PubMed Abstract | CrossRef Full Text | Google Scholar

Schultz, A. K., Zhang, M., Bulla, I., Leitner, T., Korber, B., Morgenstern, B., et al. (2009). jpHMM: improving the reliability of recombination prediction in HIV-1. Nucleic Acids Res. 37, W647–W651. doi: 10.1093/nar/gkp371

PubMed Abstract | CrossRef Full Text | Google Scholar

Shapiro, B., Rambaut, A., and Drummond, A. J. (2006). Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Mol. Biol. Evol. 23, 7–9. doi: 10.1093/molbev/msj021

PubMed Abstract | CrossRef Full Text | Google Scholar

Sierra, M., Thomson, M. M., Ríos, M., Casado, G., Ojea de Castro, R., Delgado, E., et al. (2005). The analysis of near full-length genome sequences of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Chile, Venezuela and Spain reveals their relationship to diverse lineages of recombinant viruses related to CRF12_BF. Infect. Genet. Evol. 5, 209–217. doi: 10.1016/j.meegid.2004.07.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Simonetti, F. R., Lai, A., Monno, L., Binda, F., Brindicci, G., Punzi, G., et al. (2014). Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men. Infect. Genet. Evol. 23, 176–181. doi: 10.1016/j.meegid.2014.02.007

PubMed Abstract | CrossRef Full Text | Google Scholar

Struck, D., Roman, F., De Landtsheer, S., Servais, J. Y., Lambert, C., Masquelier, C., et al. (2015). Near full-length characterization and population dynamics of the human immunodeficiency virus type 1 circulating recombinant form 42 (CRF42_BF) in Luxembourg. AIDS Res. Hum. Retroviruses 31, 554–558. doi: 10.1089/AID.2014.0364

PubMed Abstract | CrossRef Full Text | Google Scholar

Suchard, M. A., Lemey, P., Baele, G., Ayres, D. L., Drummond, A. J., and Rambaut, A. (2018). Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 4:vey016. doi: 10.1093/ve/vey016

PubMed Abstract | CrossRef Full Text | Google Scholar

Thomson, M. M., and Nájera, R. (2005). Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. AIDS Rev. 7, 210–224.

Google Scholar

Thomson, M. M., Fernández-García, A., Delgado, E., Vega, Y., Díez-Fuertes, F., Sánchez-Martínez, M., et al. (2012). Rapid expansion of a HIV-1 subtype F cluster of recent origin among men who have sex with men in Galicia, Spain. J. Acquir. Immune Defic. Syndr. 59, e49–e51. doi: 10.1097/QAI.0b013e3182400fc4

PubMed Abstract | CrossRef Full Text | Google Scholar

Thomson, M. M., Herrero, I., Villahermosa, M. L., Vázquez de Parga, E., Cuevas, M. T., Carmona, R., et al. (2002). Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J. Gen. Virol. 83, 107–119. doi: 10.1099/0022-1317-83-1-107

PubMed Abstract | CrossRef Full Text | Google Scholar

Thomson, M. M., Villahermosa, M. L., Vázquez de Parga, E., Cuevas, M. T., Delgado, E., Manjón, N., et al. (2000). Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina. AIDS 14, 897–899. doi: 10.1097/00002030-200005050-00020

PubMed Abstract | CrossRef Full Text | Google Scholar

Trifinopoulos, J., Nguyen, L. T., von Haeseler, A., and Minh, B. Q. (2016). W-IQ-TREE: a fast online phylogenetic tool for maximum likelihood analysis. Nucleic Acids Res. 44, W232–W235. doi: 10.1093/nar/gkw256

PubMed Abstract | CrossRef Full Text | Google Scholar

Vinken, L., Fransen, K., Cuypers, L., Alexiev, I., Balotta, C., Debaisieux, L., et al. (2019). Earlier initiation of antiretroviral treatment coincides with an initial control of the HIV-1 sub-subtype F1 outbreak among men-having-sex-with-men in Flanders, Belgium. Front. Microbiol. 10:613. doi: 10.3389/fmicb.2019.00613

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, M., Foley, B., Schultz, A. K., Macke, J. P., Bulla, I., Stanke, M., et al. (2010). The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology 7:25. doi: 10.1186/1742-4690-7-25

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: HIV-1, circulating recombinant form, molecular epidemiology, phylogeny, phylodynamics

Citation: Bacqué J, Delgado E, Benito S, Moreno-Lorenzo M, Montero V, Gil H, Sánchez M, Nieto-Toboso MC, Muñoz J, Zubero-Sulibarria MZ, Ugalde E, García-Bodas E, Cañada JE, del Romero J, Rodríguez C, Rodríguez-Avial I, Elorduy-Otazua L, Portu JJ, García-Costa J, Ocampo A, Cabrera JJ and Thomson MM (2021) Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin. Front. Microbiol. 12:774386. doi: 10.3389/fmicb.2021.774386

Received: 11 September 2021; Accepted: 25 October 2021;
Published: 15 November 2021.

Edited by:

Miguel Angel Martinez, IrsiCaixa, Spain

Reviewed by:

Gonzalo Jose Bello Bentancor, Oswaldo Cruz Foundation (FIOCRUZ), Brazil
Marcel Tongo, Center for Research on Emerging and Re-Emerging Diseases (CREMER), Cameroon

Copyright © 2021 Bacqué, Delgado, Benito, Moreno-Lorenzo, Montero, Gil, Sánchez, Nieto-Toboso, Muñoz, Zubero-Sulibarria, Ugalde, García-Bodas, Cañada, del Romero, Rodríguez, Rodríguez-Avial, Elorduy-Otazua, Portu, García-Costa, Ocampo, Cabrera and Thomson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Michael M. Thomson, mthomson@isciii.es

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.